Code of Practice
The Medicines New Zealand Code of Practice (Code) exists to ensure high standards of ethical and responsible promotion of prescription medicines in New Zealand, and wherever possible to exceed those required by law.
The Code represents an act of self-regulation and acceptance and observance of the Code is a condition of membership of Medicines New Zealand. Member companies must comply with both the letter and spirit of the Code.
Pharmaceutical companies that are not members of Medicines New Zealand are invited to accept and observe the Code and must comply with its provisions where required by the Advertising Standards Authority.
2019 UPDATE TO THE CODE OF PRACTICE
The Code of Practice is a living document reviewed every three years to ensure that it remains up-to-date, clear and easy to interpret. Edition 17 effective from 1 September 2019, is the latest edition of the Code.
To ensure alignment with the latest iteration of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code of Practice which was released after the publication of Edition 17 Medicines New Zealand's Code of Practice a Supplementary Guidance note (Effective 22 April 2021) has been released.